Acr Alpine Capital Research, LLC Merck & Co., Inc. Transaction History

Acr Alpine Capital Research, LLC

$4.28 Billion
Q4 2024

A detailed history of Acr Alpine Capital Research, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Acr Alpine Capital Research, LLC holds 27,539 shares of MRK stock, worth $2.38 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

27,539

Previous 15,625 76.25%

Holding current value

$2.38 Million

Previous $1.77 Million 54.4%

% of portfolio

0.06%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$96.31 - $114.76 $1.15 Million - $1.37 Million	11,914 Added 76.25%	27,539 $2.74 Million
Q3 2024 Nov 04, 2024	BUY	$111.15 - $128.97 $345,787 - $401,225	3,111 Added 24.86%	15,625 $1.77 Million
Q2 2024 Jul 31, 2024	SELL	$123.8 - $132.96 $646,112 - $693,918	-5,219 Reduced 29.43%	12,514 $1.55 Million
Q1 2024 May 06, 2024	BUY	$113.24 - $131.95 $82,212 - $95,795	726 Added 4.27%	17,733 $2.34 Million
Q4 2023 Feb 06, 2024	BUY	$100.18 - $109.02 $224,403 - $244,204	2,240 Added 15.17%	17,007 $1.85 Million
Q2 2023 Jul 24, 2023	BUY	$108.61 - $118.38 $434 - $473	4 Added 0.03%	14,767 $1.7 Million
Q1 2023 Apr 28, 2023	SELL	$102.94 - $114.86 $823 - $918	-8 Reduced 0.05%	14,763 $1.57 Million
Q4 2022 Feb 02, 2023	SELL	$87.44 - $112.11 $167,535 - $214,802	-1,916 Reduced 11.48%	14,771 $1.64 Million
Q3 2022 Oct 18, 2022	BUY	$84.53 - $94.96 $153,675 - $172,637	1,818 Added 12.23%	16,687 $1.44 Million
Q2 2022 Jul 27, 2022	BUY	$83.49 - $94.64 $6,428 - $7,287	77 Added 0.52%	14,869 $1.36 Million
Q1 2022 Apr 26, 2022	BUY	$73.51 - $82.4 $1.09 Million - $1.22 Million	14,792 New	14,792 $1.21 Million
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $160,174 - $222,008	-2,528 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$77.58 - $87.54 $543 - $612	7 Added 0.28%	2,528 $230,000
Q3 2019 Oct 31, 2019	BUY	$76.08 - $82.93 $608 - $663	8 Added 0.32%	2,521 $212,000
Q2 2019 Aug 05, 2019	BUY	$69.84 - $81.59 $488 - $571	7 Added 0.28%	2,513 $211,000
Q1 2019 May 17, 2019	SELL	$69.58 - $79.36 $14.3 Million - $16.3 Million	-205,915 Reduced 98.8%	2,506 $208,000
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $14.3 Million - $16.3 Million	205,923 Added 8243.51%	208,421 $2.51 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $456 - $529	7 Added 0.28%	2,498 $191,000
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $417,675 - $491,161	-7,240 Reduced 74.4%	2,491 $177,000
Q2 2018 Aug 03, 2018	BUY	$50.83 - $59.72 $457 - $537	9 Added 0.09%	9,731 $590,000
Q1 2018 May 09, 2018	BUY	$50.96 - $59.23 $458 - $533	9 Added 0.09%	9,722 $529,000
Q4 2017 Feb 09, 2018	BUY	$51.62 - $61.64 $18,634 - $22,252	361 Added 3.86%	9,713 $547,000
Q3 2017 Nov 07, 2017	BUY	$58.67 - $63.13 $469 - $505	8 Added 0.09%	9,352 $599,000
Q2 2017 Aug 09, 2017	BUY	N/A	9,344	9,344 $599,000

Others Institutions Holding MRK

# of Institutions

3,887

Shares Held

1.89B

Call Options Held

15.7M

Put Options Held

13.5M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $219B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acr Alpine Capital Research, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acr Alpine Capital Research, LLC with notifications on news.

Account

Acr Alpine Capital Research, LLC Merck & Co., Inc. Transaction History